← FDA Drug Approvals (Drugs@FDA)

NDA213170

NDA · New Drug Application · Sponsor: LA JOLLA PHARMA · Approved 2020-05-29

Drug application

FDA Application #

NDA213170

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

LA JOLLA PHARMA

First approval

2020-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown